Necrotising Soft Tissue Infections
Necrotising soft-tissue infections are aggressive, life-threatening infections characterised by rapidly progressing necrosis of subcutaneous tissue and fascia, with relative sparing of underlying muscle. NSTI:
- Include:
- Necrotising fasciitis
- Necrotising myositis
- Necrotising cellulitis
- Fournier’s Gangrene
When involving the perineum.
- Lead to systemic toxicity with associated multi-organ failure and high mortality
In absence of this, it may be difficult to differentiate from a severe necrotising abscess or other necrotising soft tissue infection. - Two subtypes:
- Polymicrobial necrotising fasciitis (Type 1)
- Group A Strep necrotising fasciitis (Type 2)
Epidemiology and Risk Factors
Predisposing factors for necrotising soft tissue infection include:
- Abnormal anatomy
- Previous trauma
- Previous surgery
- Obesity
- Lymphedema
- Chronic venous insufficiency
- DVT
- Vascular damage
- PVD
- Diabetes
- Smoking
- Immunosuppression
- Alcoholism
- Steroid use
- Route of entry
- IV drug use
- Pre-existing infection
Risk factors associated with ↑ mortality include:
- Age
Especially in >70 age group. - Illness severity
- Organism
Higher mortality seen with:- Group A Streptococci
- Enteric organisms
Pathophysiology
Necrotising fasciitis involves:
- Rapid proliferation of subcutaneous bacteria
- Leukocyte proliferation
- Thrombosis of fascial vessels
Leads to ischaemia and necrosis of tissue.
Toxic shock syndromes also contribute to haemodynamic instability in both Streptococcal and Staphylococcal infections.
Clinical Manifestations
Typically present as cellulitis that:
- Affects the relatively young and well
- Follows a history of minor trauma
- Is initially indistinguishable from an uncomplicated soft tissue infection, but fails to improve on antibiotics
- Has disproportionate pain to the degree of injury
- Hard, “woody” oedema of affected areas
Additional features include:
- Fever
Surprisingly rare. - Crepitus Associated with gas-forming organism infection (generally Clostridia, classically C. Perfringens) but may also occur with other bacteria such as E. Coli.
Diagnostic Approach and DDx
Investigations
Bedside:
- ABG
- Lactic acidosis
Laboratory:
- Bloods
- FBE
- UEC
- CMP
- Hypocalcaemia
- Coag
- DIC
Imaging:
- XR
- Gas in soft tissue planes
- CT
- Fascial thickening
- Contrast enhancement
- Fascial fluid collections
- Gas in soft tissue planes
- US
- Fascial fluid collections
- Gas
MRI may reveal fascial thickening and hyperintense T2 signal; however MRI is not the ideal investigation for a time-critical surgical diagnosis.
Other:
- Operative findings
- Gray necrotic fascia
- Lack of bleeding
Due to microvascular thrombosis. - “Dishwater” pus
Management
- Standard sepsis resuscitation
- Aggressive, early, surgical debridement
- Broad spectrum antibiotics with Streptococcal cover
Resuscitation:
- C
- Noradrenaline almost always required in a “true” NSTI
Specific therapy:
- Pharmacological
- Antimicrobials
- Broad-spectrum agent
- Meropenem 1g Q8H
- Amoxacillin/clavulanate 1.2g Q6-8H
- Streptococcal cover
- Clindamycin 300-450mg Q6H
- MRSA cover
- Vancomycin
- Broad-spectrum agent
- IVIG
- Associated with ↓ hospital mortality
- Antimicrobials
- Procedural
- Aggressive surgical debridement
Single most important management strategy.- Outcome improves with surgeon experienced in management
- Early debridement is critical for a good outcome
- Aggressive debridement to healthy tissue
- Aggressive surgical debridement
- Physical
- Hyperbaric Oxygen Therapy
- Controversial
- Associated with a ↓ in mortality and number of debridements, although evidence is conflicting
- Use should never delay surgical debridement
- Significant logistic impediments to use
- Availability
- Transfer of critically ill into an isolated environment
- Evidence is conflicting and some retrospective studies do not demonstrate mortality benefit
- Hyperbaric Oxygen Therapy
Antimicrobial therapy should be adjusted for known resistance patterns.
Clindamycin suppresses Streptococcal toxin production, which may ↓ severity of septic shock and is strongly associated with ↓ mortality.
The mechanism of HBOT is uncertain, possibilities include:
- ↑ Viability of marginal tissue
- ↓ Bacterial toxin production
- Inhibits anaerobic bacterial growth
↑ Tissue oxidation reduction potential. - Potentiates antibiotic function
- ↑ Efficacy of neutrophil respiratory burst
Disposition:
- ICU
Obviously required for shock requiring vasoactive support.
Complications
Prognosis
- 30% mortality with aggressive surgical intervention and appropriate antibiotics
- Frequent surgical debridements
- Long hospital stay
- Large soft tissue defects
References
- Devaney B, Frawley G, Frawley L, Pilcher DV. Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth Intensive Care. 2015 Nov;43(6):685-92. PubMed PMID: 26603791.
- Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No.: CD007937.
- Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.